|
|
Volumn 104, Issue 5, 2004, Pages 1584-1586
|
|
Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma [5] (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
ETOPOSIDE;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ADULT;
AGED;
B CELL LYMPHOMA;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
NONHODGKIN LYMPHOMA;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
SIDE EFFECT;
STANDARD;
|
|
EID: 4444260651
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood-2004-04-1266 Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|
